Trials / Recruiting
RecruitingNCT06495424
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults With Painful Diabetic Peripheral Neuropathy of the Feet
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Averitas Pharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-market observational study is to provide real-world evidence to support the repeated use of QUTENZA in patients with PDPN and to evaluate the potential for pain and concomitant medication use reduction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capsaicin 8% | Repeat applications every 12 weeks in patients with PDPN of the feet. |
Timeline
- Start date
- 2025-03-14
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2024-07-10
- Last updated
- 2026-02-17
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06495424. Inclusion in this directory is not an endorsement.